| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.15M | - | |
| Dir | 4.52M | $14.38M | - | |
| CEO | 2.26M | $7.19M | - | |
| Dir | 1.24M | $3.95M | - | |
| Other | 1.11M | $3.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $6.82 | $78,083.42 | -0.2% | -1.0% | -18.3% | |
| Jul 25, 2024 | Marriott Tina73 | President And COO | Sale+OE | 6,000 | $8.13 | $48,809.40 | -1.1% | -21.4% | -19.4% | |
| Jul 23, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $8.48 | $97,040.80 | -0.2% | -21.2% | -25.1% | |
| Jul 11, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell | 100,000 | $7.48 | $747,500.00 | -6.2% | -19.9% | -31.2% | |
| Jul 10, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE | 30,000 | $7.28 | $218,353.50 | -1.1% | -10.9% | -21.0% | |
| Jul 9, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $7.32 | $83,734.81 | -0.2% | -16.9% | -24.9% | |
| Jun 27, 2024 | Marriott Tina73 | President And COO | Sale+OE | 6,000 | $7.22 | $43,290.00 | -1.1% | -9.0% | -33.6% | |
| Jun 25, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $9.51 | $108,806.02 | -0.2% | -28.9% | -45.0% | |
| Jun 14, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE | 30,000 | $9.30 | $278,880.00 | -1.2% | -29.8% | -46.9% | |
| Jun 11, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $8.45 | $96,762.64 | -0.2% | -28.7% | -37.1% |